Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden · Delayed Price · Currency is SEK 224.00
+4.60 (2.10%)
Oct 15, 2026, 2:53 PM CET
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of 7.06 billion as of October 14, 2026. It is the 12,521st most valuable company in the world and the 158th biggest in Sweden. Its market cap has increased by 38.53% in one year.
Market Cap
7.06B
Enterprise Value
6.87B
Revenue
895.23M
Global Rank
Country Rank
#158 Sweden
PE Ratio
78.03
ChartMarket Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 371.69M to 7.06B, an increase of 1,798.31%. That is a compound annual growth rate of 23.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 7.06B | 20.04% |
| Dec 30, 2025 | 5.88B | -61.84% |
| Dec 30, 2024 | 15.40B | 48.41% |
| Dec 29, 2023 | 10.38B | 90.12% |
| Dec 30, 2022 | 5.46B | -33.55% |
| Dec 30, 2021 | 8.22B | -8.90% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sectra AB | 60.30B |
| Elekta AB | 21.96B |
| Nolato AB | 15.19B |
| Vitrolife AB | 13.01B |
| MedCap AB | 7.82B |
| CellaVision AB | 3.90B |
| BICO Group AB | 1.72B |
| Paxman AB | 1.55B |